@sdm499 @JYHYCN @WATP72RFC Furthermore, regarding this ethnocentrism, you may wish to check further on how developing nations are systemically denied through availability and affordability of treatment: https://t.co/5Vp07x0RhR https://t.co/Id4V054OIM h
“””Inadeq-HRs, financial constraints, high cost of available medications on the market, poor inventory mgnt, manual consumption forecasting, inefficiencies in drug registration,& trade-related aspects of intell-property rights agreement regulations are
RT @kchalkidou: “The poor are paying more. One of the most significant barriers to accessing essential medicines is cost.” https://t.co/rBp…
“The primary challenge, according to the review research, is a lack of adequate financing to pay for an appropriate set of essential medications” #Essential Medicines in African Countries | CEOR https://t.co/IfIOPsw5Br
“The poor are paying more. One of the most significant barriers to accessing essential medicines is cost.” https://t.co/rBpAmL3N1b